Epidemiology of hepatitis A in Ireland: Provisional – 2023 data validation ongoing
dc.contributor.author | Murphy, Niamh | |
dc.date.accessioned | 2024-03-11T15:39:29Z | |
dc.date.available | 2024-03-11T15:39:29Z | |
dc.date.issued | 2023-12 | |
dc.identifier.uri | http://hdl.handle.net/10147/641131 | |
dc.description | Hepatitis A virus • Associated with poor hygiene and sanitation • Virus shed in faeces and primarily transmitted from person-to-person via the faecal-oral route • Common source outbreaks due to contaminated food or water also occur • Incubation period (time from infection to symptoms) commonly 28-30 days (range 15-50) • Typically infectious from 2 weeks before until 1 week after onset of symptoms • Acute disease – does not have a chronic form • Lifelong or long duration immunity following infection or immunisation with hepatitis A vaccine • Clinical severity tends to increase with age. Adults can experience severe illness lasting several months, whereas young children are frequently asymptomatic • The most common symptoms are fever, loss of appetite, nausea, fatigue and abdominal pain, followed within a few days by jaundice • In developed countries, hepatitis A is most commonly seen in travellersto endemic countries, household and sexual contacts of known cases, people who inject drugs (PWID) and gay and bisexual men, and other men who have sex with men (gbMSM). | en_US |
dc.language.iso | en | en_US |
dc.publisher | Health Service Executive | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Epidemiology | en_US |
dc.subject | public health | en_US |
dc.subject | HEPATITIS A | en_US |
dc.title | Epidemiology of hepatitis A in Ireland: Provisional – 2023 data validation ongoing | en_US |
dc.type | Presentation | en_US |
dc.contributor.department | HSE Health Protection Surveillance Centre | en_US |
dc.contributor.affiliation | Health Protection Surveillance Centre (HPSC) | en |
refterms.dateFOA | 2024-03-11T15:39:30Z |